sodium arsenite has been researched along with Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, BM; Juan, WS; Lee, YP; Lin, SC; Mu, YF; So, EC; Wang, CY | 1 |
| Moon, SL; Morisaki, T; Parker, R; Stasevich, TJ | 1 |
| Ahn, JS; Ahn, MJ; Han, R; Kang, WK; Kim, J; Kim, S; Lee, J; Lim, HY; Park, JO; Park, YS; Sun, JM | 1 |
| Beumer, JH; Edelman, MJ; Feliciano, J; Gobbru, J; Lapidus, R; Liu, T; Styblo, M | 1 |
| Fujishiro, H; Himeno, S; Matsumoto, K; Satoh, M; Shimizu, Y; Sumi, D | 1 |
| Jiang, R; Li, Y; Ling, M; Liu, Q; Pang, Y; Shen, L; Wang, X; Xu, Y; Zhang, J; Zhao, Y; Zhou, J; Zhou, Y | 1 |
| Hanson, J; Le, XC; Lee, J; Mei, N; Sun, X; Weinfeld, M; Xing, JZ | 1 |
| Datta, R; Sarkar, D | 1 |
| Eddy, K; Kelsey, KT; Marsit, CJ | 1 |
| Hahn, GM; Mivechi, NF; Monson, JM | 1 |
2 trial(s) available for sodium arsenite and Neoplasms
| Article | Year |
|---|---|
Phase I clinical trial of KML001 monotherapy in patients with advanced solid tumors.
Topics: Adult; Aged; Antineoplastic Agents; Arsenites; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Sodium Compounds; Treatment Outcome | 2020 |
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic; Arsenites; Cisplatin; Endpoint Determination; Enzyme Inhibitors; Female; Humans; Long QT Syndrome; Male; Middle Aged; Neoplasms; Platinum; Sodium Compounds; Telomerase; Treatment Outcome | 2016 |
8 other study(ies) available for sodium arsenite and Neoplasms
| Article | Year |
|---|---|
Arsenic compounds activate MAPK and inhibit Akt pathways to induce apoptosis in MA-10 mouse Leydig tumor cells.
Topics: Animals; Apoptosis; Arsenites; Caspases; Mice; Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2023 |
Coupling of translation quality control and mRNA targeting to stress granules.
Topics: Antigens, Neoplasm; Arsenites; Cytoplasmic Granules; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Kinetics; Neoplasms; Nucleocytoplasmic Transport Proteins; Proteasome Endopeptidase Complex; Protein Biosynthesis; Protein Transport; Proteostasis; Ribosomes; RNA, Messenger; Sodium Compounds; Ubiquitin-Protein Ligases; Valosin Containing Protein | 2020 |
Chronic exposure to arsenite induces S100A8 and S100A9 expression in rat RBL-2H3 mast cells.
Topics: Animals; Arsenites; Atherosclerosis; Calgranulin A; Calgranulin B; Gene Expression Profiling; Leukemia, Basophilic, Acute; Mast Cells; Microarray Analysis; Neoplasms; Rats; RNA, Messenger; Sodium Compounds; Time Factors; Tumor Cells, Cultured; Up-Regulation; Water Pollutants, Chemical | 2011 |
Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes.
Topics: Animals; Apoptosis; Arsenites; Blotting, Southwestern; Blotting, Western; Cell Culture Techniques; Cell Line; Cell Survival; Cell Transformation, Neoplastic; DNA Damage; Dose-Response Relationship, Drug; HSP70 Heat-Shock Proteins; Humans; Immunoprecipitation; Inhibitor of Apoptosis Proteins; Keratinocytes; MAP Kinase Signaling System; Mice; Mice, Nude; Mitochondrial Proteins; Neoplasms; Real-Time Polymerase Chain Reaction; Sodium Compounds; Survivin; Tumor Suppressor Protein p53 | 2012 |
Genetic predisposition to the cytotoxicity of arsenic: the role of DNA damage and ATM.
Topics: Animals; Arsenites; Ataxia Telangiectasia Mutated Proteins; Carcinogens; Cell Cycle; Cell Cycle Proteins; Cell Line; CHO Cells; Cricetinae; DNA Damage; DNA Repair; DNA-Binding Proteins; Genetic Predisposition to Disease; Humans; Models, Biological; Mutation; Neoplasms; Phosphorylation; Protein Serine-Threonine Kinases; Sodium Compounds; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2003 |
Consideration of soil properties in assessment of human health risk from exposure to arsenic-enriched soils.
Topics: Arsenic; Arsenites; Biological Availability; Child; Environmental Exposure; Gastric Juice; Humans; Intestinal Absorption; Metals; Neoplasms; Pesticides; Risk Assessment; Sodium Compounds; Soil; Soil Pollutants | 2005 |
MicroRNA responses to cellular stress.
Topics: Arsenites; Folic Acid Deficiency; Humans; Lymphocytes; MicroRNAs; Neoplasms; Sodium Compounds | 2006 |
Expression of HSP-28 and three HSP-70 genes during the development and decay of thermotolerance in leukemic and nonleukemic human tumors.
Topics: Arsenic; Arsenites; Base Sequence; Cell Survival; Electrophoresis, Gel, Two-Dimensional; Gene Expression; Heat-Shock Proteins; Hot Temperature; Humans; Hyperthermia, Induced; In Vitro Techniques; Leukemia; Molecular Sequence Data; Neoplasms; Oligodeoxyribonucleotides; Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Sodium Compounds; Tumor Cells, Cultured | 1991 |